• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Profound Medical Corp. - common stock (NQ:PROF)

    5.530 -0.030 (-0.54%)
    Streaming Delayed Price Updated: 3:58 PM EDT, Oct 17, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 12,877
    Open 5.540
    Bid (Size) 5.510 (1)
    Ask (Size) 5.570 (4)
    Prev. Close 5.560
    Today's Range 5.340 - 5.660
    52wk Range 3.760 - 9.170
    Shares Outstanding 20,208,948
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Profound Medical Congratulates the Busch Center for Achieving 500th TULSA Procedure Milestone
    Clinical validation from the Busch Center highlights the proven, scalable innovation driving a paradigm shift in prostate care — delivering precision treatment and better patient outcomes 
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical to Participate in the Stifel 2025 Healthcare Conference
    From Profound Medical Corp.
    Via GlobeNewswire

    Performance

    YTD
    -30.0%
    -30.0%
    1 Month
    +36.9%
    +36.9%
    3 Month
    -2.9%
    -2.9%
    6 Month
    +15.7%
    +15.7%
    1 Year
    -27.3%
    -27.3%

    More News

    Read More
    Earnings Scheduled For August 14, 2025
    Via Benzinga
    Earnings Scheduled For May 8, 2025
    Via Benzinga
    Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical to Participate in Lake Street’s 9th Annual Best Ideas Growth Conference
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical Posts Wider Loss in Q2
    Via The Motley Fool
    Texas Prostate and Dallas Medical Center Launch First-of-its-Kind TULSA Program, Expanding Access to Advanced Prostate Treatment
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical Announces Second Quarter 2025 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical to Release Second Quarter 2025 Financial Results on August 14 – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical Announces First Commercial BPH Patient Treatment Using TULSA-PRO® with TULSA-AI® Volume Reduction
    From Profound Medical Corp.
    Via GlobeNewswire
    Famed Former NFL Safety, Leonard Wheeler, Named Global Ambassador For TULSA-PRO®
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical Annual General and Special Meeting of Shareholders Voting Results
    From Profound Medical Corp.
    Via GlobeNewswire
    Why Coinbase Global Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session
    Via Benzinga
    Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Profound Medical Announces First Quarter 2025 Financial Results
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical to Participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference
    From Profound Medical Corp.
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
    From Pomerantz LLP
    Via GlobeNewswire
    Initial Perioperative Data from CAPTAIN Randomized Trial Demonstrate MRI-Guided TULSA Provides Statistically Significant Improvement of Post-Operative Experience Vs. Robotic Radical Prostatectomy
    From Profound Medical Corp.
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
    From Pomerantz LLP
    Via GlobeNewswire
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Profound Medical Corp. - PROF
    From Pomerantz LLP
    Via GlobeNewswire
    Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow
    From Profound Medical Corp.
    Via GlobeNewswire
    Profound Medical AUA 2025 Investor Event Agenda
    From Profound Medical Corp.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Profound Medical Corp. - common stock publicly traded?
    Yes, Profound Medical Corp. - common stock is publicly traded.
    What exchange does Profound Medical Corp. - common stock trade on?
    Profound Medical Corp. - common stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Profound Medical Corp. - common stock?
    The ticker symbol for Profound Medical Corp. - common stock is PROF on the Nasdaq Stock Market
    What is the current price of Profound Medical Corp. - common stock?
    The current price of Profound Medical Corp. - common stock is 5.530
    When was Profound Medical Corp. - common stock last traded?
    The last trade of Profound Medical Corp. - common stock was at 10/17/25 03:58 PM ET
    What is the market capitalization of Profound Medical Corp. - common stock?
    The market capitalization of Profound Medical Corp. - common stock is 111.76M
    How many shares of Profound Medical Corp. - common stock are outstanding?
    Profound Medical Corp. - common stock has 112M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.